LCG
AXNX

Lisanti Capital Growth’s Axonics, Inc. Common Stock AXNX Stock Holding History

Lisanti Capital Growth’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-106,950
Closed -$6.66M – 160
2023
Q4 		$6.66M Buy
106,950
+31,400
+42% +$1.76M 1.57% 14
2023
Q3 		$4.24M Buy
75,550
+59,090
+359% +$3.32M 0.67% 62
2023
Q2 		$831K Sell
16,460
-41,895
-72% -$2.23M 0.12% 135
2023
Q1 		$3.18M Sell
58,355
-85,942
-60% -$5.02M 0.44% 88
2022
Q4 		$9.02M Buy
144,297
+37,025
+35% +$2.46M 1.23% 27
2022
Q3 		$7.56M Sell
107,272
-2,770
-3% -$191K 1.01% 42
2022
Q2 		$6.24M Sell
110,042
-20,358
-16% -$1.12M 0.85% 49
2022
Q1 		$8.16M Buy
+130,400
New +$7.03M 0.92% 44
2021
Q4 		– Sell
-66,499
Closed -$4.33M – 154
2021
Q3 		$4.33M Sell
66,499
-66,731
-50% -$4.55M 0.64% 67
2021
Q2 		$8.45M Sell
133,230
-1,895
-1% -$112K 1.05% 29
2021
Q1 		$8.09M Buy
+135,125
New +$7.35M 1.04% 36

Other funds holding AXNX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Lisanti Capital Growth's AXNX Position: Q1 2024 in Review

Lisanti Capital Growth sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2024, closing a stake of 106,950 shares — an estimated $6.66M sold.

Lisanti Capital Growth first reported a position in AXNX in Q1 2021 and held it in 11 quarters. The position peaked at $9.02M in Q4 2022. 235 funds tracked by Wall St. Rank hold AXNX as of Q1 2024.

  • Lisanti Capital Growth reported no remaining Axonics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Lisanti Capital Growth sold 106,950 Axonics, Inc. Common Stock shares in Q1 2024, an estimated $6.66M.
  • Lisanti Capital Growth first reported a position in Axonics, Inc. Common Stock in Q1 2021 and held it in 11 quarters.
  • Lisanti Capital Growth's Axonics, Inc. Common Stock position peaked at $9.02M in Q4 2022.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2024.

Based on Lisanti Capital Growth's 13F filing for Q1 2024, filed 7 May 2024.